River blindness and the black flies that cause it torment millions in west Africa. The “slash and clear” method is an effective way to eliminate them at source.
Academic rigor, journalistic flair
Articles on Ivermectin
Displaying all articles
A new screening tool to help study reviewers identify what’s fake or shoddy in research may be on the horizon. And everyday people can apply some of the same critical analysis tools.
Mainstream medicine hasn’t yet found enough evidence-based treatments for long COVID. No wonder sufferers are turning to unproven therapies.
Good science doesn’t eliminate uncertainty: it explains it.
Ivermectin is vital for controlling a number of neglected tropical diseases, but mixed messaging and reported side-effects from its misuse against COVID could turn patients off it.
Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.
The path to using old drugs for COVID is full of potholes. So why are we using the same old flawed methods when we actually know what works?
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
Ivermectin is the most recent example of a medication touted as a miracle drug for COVID-19 without solid medical evidence supporting its use.
Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
Investigations have led to the withdrawal of a study backing ivermectin to treat COVID-19. But that’s not the last time we’ll hear about this controversial drug.
The antiparasitic drug was thought to be a potential treatment for COVID-19, but there isn’t sufficient evidence to recommend its use, despite widespread support online.
CC BY-NC-ND15.8 MB (download)
What’s all the excitement around ivermectin? Can it actually help treat COVID-19 patients?
The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
The head lice drug Ivermectin has stopped SARS-CoV-2, the virus that causes COVID-19, from replicating in lab tests. But we don’t know if it will work as a treatment for people with coronavirus.
A cure for many tropical diseases was discovered 30 years ago this month. The drug is donated by its manufacturer. Why are we still dealing with neglected tropical diseases?
Although a drug of known safety and efficacy is available, scabies still affects more than 100 million people across the world.
The 2015 Nobel Prize in medicine went to research on remedies derived from natural compounds. Academia is continuing the fight against ‘neglected’ diseases by similarly hunting for new drugs in nature.
Top contributors
-
Head of School and Dean of Pharmacy, University of Sydney
-
Ph.D. Candidate in Microbiology, Harvard University
-
Group Leader, Murdoch Childrens Research Institute. Associate Professor, Department of Paediatrics, University of Melbourne. Paediatric Infectious Diseases Physician, Royal Children's Hospital, Murdoch Children's Research Institute
-
Professor of Chemistry, Northeastern University
-
University of Johannesburg
-
Research project Manager, PhD candidate at University of Antwerp, University of Antwerp
-
Professor and Deputy Director/NHMRC Fellow, Institute for Glycomics, Griffith University
-
Senior researcher at the Africa Centre for Evidence, University of Johannesburg
-
Professor Biochemistry and Pharmacology and Director, Bio21 Institute, The University of Melbourne
-
SHARP Professor, Vitalities Lab, Centre for Social Research in Health and Social Policy Centre, and the ARC Centre of Excellence for Automated Decision-Making and Society, UNSW Sydney
-
FAR-LeaF Fellow, University of Pretoria
-
Senior Lecturer, University of Sydney
-
Research Professor in Medicinal Chemistry and Drug Discovery, Monash Institute of Pharmaceutical Sciences, Monash University
-
Dean Faculty of Veterinary Science and specialist in veterinary pharmacology, University of Pretoria
-
Professor: Evidence-Informed Decision-Making, University of Johannesburg
